HAE FY 2014 Earnings Report — Haemonetics Corporation Revenue & Financial Results | Market Cap Arena

Haemonetics CorporationHAE

FY 2014 Earnings

Reported May 22, 2014

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2014	Prior Q	FY 2013	QoQ Change	YoY Change
Revenue	$939M	—	$892M	—	5.2%
Op. Income	$47M	—	$56M	—	-16.1%
Gross Margin	49.9%	—	48.0%	—	1.9pp
Net Margin	3.7%	—	4.3%	—	-0.6pp
EPS (Diluted)	$0.67	—	$0.74	—	-9.5%
Free Cash Flow	$66M	—	$23M	—	187.8%

Revenue Flow

Item	Amount
REVENUE	$939M
Cost of Revenue	$470M
GROSS PROFIT	$468M
R&D Expenses	$54M
Selling & Marketing	$4M
General & Administrative	$363M
SG&A Expenses	$367M
Other Expenses	$2M
Operating Expenses	$421M
Cost & Expenses	$891M
OPERATING INCOME	$47M
Interest Income	$0
Interest Expense	$11M
Other Income/Expenses	-$11M
INCOME BEFORE TAX	$36M
Income Tax Expense	$1M
Net Income from Continuing Ops	$35M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$35M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$35M
D&A	$82M
EBIT	$48M
EBITDA	$127M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$939M
Cost of Revenue	$470M
GROSS PROFIT	$468M
R&D Expenses	$54M
Selling & Marketing	$4M
General & Administrative	$363M
SG&A Expenses	$367M
Other Expenses	$2M
Operating Expenses	$421M
Cost & Expenses	$891M
OPERATING INCOME	$47M
Interest Income	$0
Interest Expense	$11M
Other Income/Expenses	-$11M
INCOME BEFORE TAX	$36M
Income Tax Expense	$1M
Net Income from Continuing Ops	$35M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$35M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$35M
D&A	$82M
EBIT	$48M
EBITDA	$127M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$35M
Depreciation & Amortization	$82M
Stock-Based Compensation	$13M
Deferred Income Tax	-$202.0K
Other Non-Cash Items	$10M
Change in Working Capital	$237.0K
OPERATING CASH FLOW	$140M
Capital Expenditure	-$74M
Acquisitions (Net)	-$33M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$73M
NET CASH FROM INVESTING	-$106M
Net Debt Issuance	-$44M
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$2M
NET CASH FROM FINANCING	-$21M
FREE CASH FLOW	$66M
Net Change in Cash	$13M

Balance Sheet

Item	Amount
Cash & Equivalents	$192M
Short-Term Investments	$0
Net Receivables	$165M
Inventory	$198M
Other Current Assets	$68M
TOTAL CURRENT ASSETS	$630M
PP&E (Net)	$271M
Goodwill	$337M
Intangible Assets	$271M
Long-Term Investments	-$609M
Tax Assets	$1M
Other Non-Current Assets	$620M
TOTAL NON-CURRENT ASSETS	$891M
TOTAL ASSETS	$1.5B
Account Payables	$54M
Short-Term Debt	$46M
Deferred Revenue	$25M
Other Current Liabilities	$35M
TOTAL CURRENT LIABILITIES	$218M
Long-Term Debt	$392M
Deferred Revenue NC	-$30M
Deferred Tax Liabilities	$30M
Other Non-Current Liabilities	$38M
TOTAL NON-CURRENT LIABILITIES	$463M
TOTAL LIABILITIES	$681M
Common Stock	$520.0K
Additional Paid-In Capital	$403M
Retained Earnings	$433M
Treasury Stock	$0
Accum. Other Comp. Income	$1M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$840M
Minority Interest	$0
TOTAL EQUITY	$840M
TOTAL LIABILITIES & EQUITY	$1.5B
Total Debt	$438M
Net Debt	$245M